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Celia Alpuche-Aranda, M.D., Ph.D., Mauricio Hernandez, M.D., Ph.D.,
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Background
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University, Tempe (G.C.); the National
Institute of Public Health, Center for
Evaluation Research and Surveys, Cuernavaca, Mexico (S.M.B., M.A.C.); the
University of California, Berkeley
(S.M.B.); and the Mexican Ministry of
Health, Mexico City (H.L.-G., C.A.-A.,
M.H.). Address reprint requests to Dr.
Bertozzi at Instituto Nacional de Salud
Publica, Av. Universidad 655, Cuernavaca
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insp.mx.
This article (10.1056/NEJMoa0904023) was
published on June 29, 2009, at NEJM.org.
N Engl J Med 2009;361:674-9.
Copyright © 2009 Massachusetts Medical Society.

In the spring of 2009, an outbreak of severe pneumonia was reported in conjunction with the concurrent isolation of a novel swine-origin influenza A (H1N1) virus
(S-OIV), widely known as swine flu, in Mexico. Influenza A (H1N1) subtype viruses
have rarely predominated since the 1957 pandemic. The analysis of epidemic pneumonia in the absence of routine diagnostic tests can provide information about risk
factors for severe disease from this virus and prospects for its control.
Methods

From March 24 to April 29, 2009, a total of 2155 cases of severe pneumonia, involving 821 hospitalizations and 100 deaths, were reported to the Mexican Ministry of
Health. During this period, of the 8817 nasopharyngeal specimens that were submitted
to the National Epidemiological Reference Laboratory, 2582 were positive for S-OIV.
We compared the age distribution of patients who were reported to have severe pneumonia with that during recent influenza epidemics to document an age shift in rates
of death and illness.
Results

During the study period, 87% of deaths and 71% of cases of severe pneumonia involved patients between the ages of 5 and 59 years, as compared with average rates of
17% and 32%, respectively, in that age group during the referent periods. Features
of this epidemic were similar to those of past influenza pandemics in that circulation of the new influenza virus was associated with an off-season wave of disease affecting a younger population.
Conclusions

During the early phase of this influenza pandemic, there was a sudden increase in the
rate of severe pneumonia and a shift in the age distribution of patients with such
illness, which was reminiscent of past pandemics and suggested relative protection
for persons who were exposed to H1N1 strains during childhood before the 1957
pandemic. If resources or vaccine supplies are limited, these findings suggest a rationale for focusing prevention efforts on younger populations.
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I

n early April 2009, a sharp increase in
reports of patients requiring hospitalization for
pneumonia and an unusual series of deaths
were reported to the Mexican Ministry of Health.
The National Epidemiological Surveillance System
(SINAVE), a nationwide interagency system led by
the Directorate General of Epidemiology,1 noted a
particular increase among adults between the ages
of 20 and 40 years and an increase in cases of laboratory-confirmed influenza. Typically, in Mexico, seasonal influenza is observed from October
through March,2 with an appreciable increase in
the rate of death among the elderly,3 similar to
the pattern observed in other temperate climates,
such as the United States.4,5 The concurrent finding of a swine-origin influenza A (H1N1) virus
(S-OIV)6 from infected children in the United
States7 prompted a rapid response from the Mexican public health emergency system.
From March 24 through April 29, 2009, there
were reports of 2155 cases of severe pneumonia,
including 100 deaths, to the SINAVE system in
response to requests for data on patients who had
required hospitalization for severe pneumonia.
During this period, of the 8817 nasopharyngeal
specimens that were submitted to the National
Epidemiological Reference Laboratory, 3664 (42%)
tested positive for influenza subtype A; of these
specimens, 2582 (70%) were confirmed as S-OIV
by reverse-transcriptase–polymerase-chain-reaction
(PCR) assay.
In this article, we evaluate the reported case
series of severe pneumonia and compare the age
patterns with respect to morbidity and mortality
with patterns from recent influenza epidemics in
Mexico. Crucial epidemiologic factors, such as the
age pattern of morbidity and mortality during the
2009 epidemic, are inferred because of the limited
availability of diagnostic tests and data. Given the
relatively rapid global spread of this newly described pathogen,8 early identification of groups
at risk for severe pneumonia can aid in prioritizing the use of vaccines and antiviral drugs in the
face of limited supplies.

Me thods
Epidemiologic Surveillance

The SINAVE was established in September 1995
to harmonize surveillance procedures nationally.
SINAVE receives weekly reports of 117 notifiable
conditions from 19,715 of 20,472 (96%) public and
private primary care clinics and hospitals in Mexn engl j med 361;7

ico. Since 2006, surveillance of influenza-like illness with testing for influenza virus has been conducted in sentinel units in all 32 states, increasing
from 380 sentinel units in 2006 to 520 in 2008.
Influenza-like illness is defined as fever, cough,
and headache, accompanied by one or more of the
following signs or symptoms: rhinorrhea, coryza,
arthralgia, myalgia, prostration, odynophagia,
chest pain, abdominal pain, and nasal congestion.
Nasopharyngeal swabs are taken from a proportion of patients and processed with the use of an
immunofluorescence assay for influenza. Positive
specimens are then sent to the National Epidemiological Reference Laboratory for PCR testing.
The proportion of specimens that are confirmed
as positive typically ranges from 7.5 to 9.0% during influenza season.
On April 14 and April 15, 2009, the Mexican
Ministry of Health received notification from several cities of cases of severe pneumonia affecting
mostly young persons, coupled with an increase
in the number of cases and outbreaks of seasonal
influenza observed since February. Responding to
this situation, on April 17, the Ministry of Health
issued an epidemiologic alert and requested that
medical institutions in all Mexican states intensify
notification regarding patients requiring hospitalization for pneumonia through an Internet-based
platform. Individual case records were reported
online to the SINAVE, including the date of the
onset of symptoms, the date of hospitalization, the
institution reporting the case, and the patient’s age,
sex, and state of residence. Since influenza season
normally ends in March, few of the original samples from patients during this period had undergone laboratory testing to diagnose inf luenza.
Study Period

Without knowing when the index case of S-OIV
infection occurred, we defined the study period as
the interval from the date of the onset of symptoms in the patient with the earliest suspected case
of atypical pneumonia (March 24) to April 29, when
selective reporting of severe pneumonia ceased.
We reviewed the records of 2155 patients with severe pneumonia in the database. Of these records,
821 (38%) indicated a date of hospitalization for
pneumonia, and 100 (5%) involved deaths of patients. Although the SINAVE system captured only
a portion of all hospitalizations for pneumonia,
it provided the best data currently available on the
rate of increase in severe pneumonia during this
period.
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Figure 1. Time Series of Confirmed Cases of Influenza in the Federal District and inRETAKE
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These data show a sudden increase in the rate of
severe pneumonia and a shift in the age distribution of patients with such illness, which were concurrent with person-to-person circulation of S-OIV
infection in Mexico. Although the epidemiologic,
clinical, and virologic characteristics of this outbreak are evolving, this wave of pneumonia is reminiscent of the initial phase of pandemics from
the last century.10 These factors include the documentation of a novel pathogenic influenza virus
and a shift in the ages of patients who become ill
or die.11 Early waves of respiratory illness in young
adults were observed before the 1918 influenza
pandemic in New York,12 Copenhagen,13 the United
Kingdom,14 and Geneva,15 as well as among members of the U.S. military.16 The apparent population effect of S-OIV infection has several signature features17 of previous pandemics, including
atypical timing and age shifts in disease severity.
Case ascertainment for the specific diagnosis
of S-OIV infection has been limited, given the lack
of commercially available tests for this virus and
the scarcity of reagents in the setting of an evolving global epidemic. We address this challenge
through analyses of data before, during, and after
the initial acceleration of reporting activities, as
well as through stratification according to region.
We have also compared the data with those obtained during periods of seasonal epidemic influenza. Given variable underreporting, we have
based our comparisons on proportionate distributions. Unless there are systemic biases in reporting according to age group, this approach provides
a reasonable approach for comparison.
Although many cases of severe pneumonia have
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Percentage increases in death were seen in subgroups of patients between the ages of 5 and 59
years, representing 87% of deaths from severe
pneumonia during the study, as compared with
17% on average during previous epidemic periods.
Percentage increases ranged from a factor of 1.2
to a factor of 11.7, with percentage decreases in
the subgroup of patients under 4 years of age
(0.3) and in subgroups of patients 60 years of age
or older (0 to 0.3) (Table 1). Shifts in morbidity
were pronounced, with 71% of cases of severe
pneumonia occurring in patients between the ages
of 5 and 59 years, as compared with an average
of 32% of cases in that age group during the referent periods (Fig. 3).
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confirmed S-OIV infection (44%) lead us to believe that a large proportion of the reported cases
are probably associated with this novel pathogen.
A similar study that was performed in Denmark
during the 1918 outbreak indicated that during a
wave of atypical pneumonia, there was an increase
by a factor of 20 in incidence, as compared with
that in preceding years, which implied that influenza was the putative agent.13
Influenza A (H1N1) viruses were in circulation
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Table 1. Proportion of Mortality from Severe Pneumonia According to Age
Group during the 2009 Study Period, as Compared with Influenza Seasons
from 2006 through 2008, in Mexico.*
Age Group

Mortality
2006–2008 Influenza
Seasons

yr

March 24 to
April 29, 2009

Ratio, Study Period
to Referent Period

percent

0–4

17

5

0.3

5–9

1

5

7.6

10–14

1

6

10.7

15–19

1

7

8.6

20–24

1

13

11.7

25–29

1

11

10.3

30–34

1

9

6.0

35–39

2

15

9.4

40–44

2

9

4.8

45–49

2

5

2.1

50–54

2

4

1.6

55–59

3

3

1.2

60–64

3

0

0.0

65–69

5

1

0.2

70–74

7

2

0.3

75–79

9

2

0.2

42

3

0.1

≥80

* Data were reported by the National System of Health Care Information and
the National Epidemiological Surveillance System (SINAVE).

from 1918 through 1957, and genetically similar
isolates, most likely representing a laboratory escape, reemerged in 1977 to periodically cocirculate with A (H3N2) subtypes. In 1976, a limited
number of swine-influenza cases set off a massive vaccine campaign to control a potential pandemic, which fortunately never occurred. However, unlike the situation in 1976, epidemiologic
evidence from this outbreak indicates that there
were continuous chains of person-to-person transmission for several viral generations. Since the
discovery of influenza viruses, the past two influenza pandemics have been characterized by
novel subtypes. Although humans have previously
been exposed to the influenza A (H1N1) subtype,
this novel virus has made a host-species jump with
sustained human-to-human transmission.
In 1918, patients who were documented with
illness during the early waves of severe pneumonia in Denmark and among members of the U.S.
678
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military were less likely to be ill in the later wave
of the pandemic,13,16 which suggests the possibility of natural infection with a less virulent but antigenically similar virus in the general population.
It is unclear whether this circulating virus would
have a similar effect if it recirculated after the initial wave. Likewise, childhood exposure to influenza A (H1N1) viruses in persons who were born
before 1957, when these viruses circulated widely,
may have conferred some level of protection.
Of note, during the study period, there was
proportionately lower morbidity among persons
who were 60 years of age or older, the age group
in which all persons were born before the 1957
pandemic. With an annual influenza incidence of
15 to 20%, most of these persons would have been
first exposed to influenza A (H1N1) strains, which
disappeared from circulation after the 1957 A
(H2N2) influenza pandemic. Francis described the
concept of “original antigenic sin,” in which the
immune response is greatest to antigens to which
first exposure occurred in childhood.18 According
to this concept, persons born before 1957 who
were exposed in childhood to influenza A (H1N1)
viruses might be better protected against this viral subtype than those who were first exposed to
other influenza A subtypes, H2N2 and H3N2, at
a later date. Age shifts in mortality to younger
populations during pandemics have been described
from the reemergence of a subtype.19 Although
persons who were born after 1977 may have been
first exposed to an influenza A (H1N1) subtype
virus, such strains rarely predominate. In this data
series, persons who were 60 years of age or older
were proportionately less likely to have severe
pneumonia, a consideration for future strategies
for vaccine allocation.20
An early wave of influenza in northern England
during the 1951 influenza season was documented with even higher mortality than that of the
1918 pandemic, but the situation never evolved into
a pandemic.21 Similarly, the public health community acted swiftly to develop a vaccine in response
to human cases of swine influenza in 1976, and a
pandemic did not occur.22 During the early phase
of this epidemic, the rapid identification of persons who are likely to have severe disease, as
compared with those who are likely to have mild
disease, can guide epidemic or pandemic response strategies. Our outline of the age-stratification profile of risk provides a possible foundation for control strategies on the basis of the
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biologic plausibility of partial protection from
earlier exposure. Further studies are under way
in Mexico to elucidate other potential risk factors
for severity of S-OIV infection to guide targeted
control efforts.
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